Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 406

1.

Adolescent and young adult oncology-past, present, and future.

Close AG, Dreyzin A, Miller KD, Seynnaeve BKN, Rapkin LB.

CA Cancer J Clin. 2019 Oct 8. doi: 10.3322/caac.21585. [Epub ahead of print]

2.

Breast cancer statistics, 2019.

DeSantis CE, Ma J, Gaudet MM, Newman LA, Miller KD, Goding Sauer A, Jemal A, Siegel RL.

CA Cancer J Clin. 2019 Oct 2. doi: 10.3322/caac.21583. [Epub ahead of print]

3.

Acceptance and commitment therapy for breast cancer survivors with fear of cancer recurrence: A 3-arm pilot randomized controlled trial.

Johns SA, Stutz PV, Talib TL, Cohee AA, Beck-Coon KA, Brown LF, Wilhelm LR, Monahan PO, LaPradd ML, Champion VL, Miller KD, Giesler RB.

Cancer. 2019 Sep 20. doi: 10.1002/cncr.32518. [Epub ahead of print]

PMID:
31539169
4.

Cancer statistics for adults aged 85 years and older, 2019.

DeSantis CE, Miller KD, Dale W, Mohile SG, Cohen HJ, Leach CR, Goding Sauer A, Jemal A, Siegel RL.

CA Cancer J Clin. 2019 Aug 7. doi: 10.3322/caac.21577. [Epub ahead of print]

5.

Profiling molecular regulators of recurrence in chemorefractory triple-negative breast cancers.

Hancock BA, Chen YH, Solzak JP, Ahmad MN, Wedge DC, Brinza D, Scafe C, Veitch J, Gottimukkala R, Short W, Atale RV, Ivan M, Badve SS, Schneider BP, Lu X, Miller KD, Radovich M.

Breast Cancer Res. 2019 Aug 5;21(1):87. doi: 10.1186/s13058-019-1171-7.

6.

Immune-Mediated Control of a Dormant Neurotropic RNA Virus Infection.

Miller KD, Matullo CM, Milora KA, Williams RM, O'Regan KJ, Rall GF.

J Virol. 2019 Aug 28;93(18). pii: e00241-19. doi: 10.1128/JVI.00241-19. Print 2019 Sep 15.

PMID:
31270232
7.

National and State Estimates of Lost Earnings From Cancer Deaths in the United States.

Islami F, Miller KD, Siegel RL, Zheng Z, Zhao J, Han X, Ma J, Jemal A, Yabroff KR.

JAMA Oncol. 2019 Jul 3. doi: 10.1001/jamaoncol.2019.1460. [Epub ahead of print]

PMID:
31268465
8.

Proton Beam Therapy and Immune Checkpoint Inhibitors in Malignant Pleural Mesothelioma.

McCusker MG, Scilla KA, Simone CB 2nd, Sachdeva A, Miller KD, Burke AP, Rolfo C.

J Thorac Oncol. 2019 Sep;14(9):e185-e187. doi: 10.1016/j.jtho.2019.05.013. Epub 2019 Jun 22. No abstract available.

PMID:
31235402
9.

Cancer treatment and survivorship statistics, 2019.

Miller KD, Nogueira L, Mariotto AB, Rowland JH, Yabroff KR, Alfano CM, Jemal A, Kramer JL, Siegel RL.

CA Cancer J Clin. 2019 Sep;69(5):363-385. doi: 10.3322/caac.21565. Epub 2019 Jun 11.

10.

Personalized Decision Making in Early Stage Breast Cancer: Applying Clinical Prediction Models for Anthracycline Cardiotoxicity and Breast Cancer Mortality Demonstrates Substantial Heterogeneity of Benefit-Harm Trade-off.

Upshaw JN, Ruthazer R, Miller KD, Parsons SK, Erban JK, O'Neill AM, Demissei B, Sledge G, Wagner L, Ky B, Kent DM.

Clin Breast Cancer. 2019 Aug;19(4):259-267.e1. doi: 10.1016/j.clbc.2019.04.012. Epub 2019 May 2.

PMID:
31175052
11.

Condition-Dependent Begging Elicits Increased Parental Investment in a Wild Bird Population.

Bowers EK, Jenkins JB, Mueller AJ, Miller KD, Thompson CF, Sakaluk SK.

Am Nat. 2019 May;193(5):725-737. doi: 10.1086/702848. Epub 2019 Mar 14.

12.

Dual TGFβ/BMP Pathway Inhibition Enables Expansion and Characterization of Multiple Epithelial Cell Types of the Normal and Cancerous Breast.

Prasad M, Kumar B, Bhat-Nakshatri P, Anjanappa M, Sandusky G, Miller KD, Storniolo AM, Nakshatri H.

Mol Cancer Res. 2019 Jul;17(7):1556-1570. doi: 10.1158/1541-7786.MCR-19-0165. Epub 2019 Apr 16.

PMID:
30992305
13.

Nest microclimate during incubation affects posthatching development and parental care in wild birds.

Mueller AJ, Miller KD, Bowers EK.

Sci Rep. 2019 Mar 26;9(1):5161. doi: 10.1038/s41598-019-41690-4.

14.

Cancer statistics for African Americans, 2019.

DeSantis CE, Miller KD, Goding Sauer A, Jemal A, Siegel RL.

CA Cancer J Clin. 2019 May;69(3):211-233. doi: 10.3322/caac.21555. Epub 2019 Feb 14.

15.

Association of Magnetic Resonance Imaging and a 12-Gene Expression Assay With Breast Ductal Carcinoma In Situ Treatment.

Lehman CD, Gatsonis C, Romanoff J, Khan SA, Carlos R, Solin LJ, Badve S, McCaskill-Stevens W, Corsetti RL, Rahbar H, Spell DW, Blankstein KB, Han LK, Sabol JL, Bumberry JR, Gareen I, Snyder BS, Wagner LI, Miller KD, Sparano JA, Comstock C.

JAMA Oncol. 2019 Jul 1;5(7):1036-1042. doi: 10.1001/jamaoncol.2018.6269.

PMID:
30653209
16.

Poly-ADP-Ribosylation of Estrogen Receptor-Alpha by PARP1 Mediates Antiestrogen Resistance in Human Breast Cancer Cells.

Pulliam N, Tang J, Wang W, Fang F, Sood R, O'Hagan HM, Miller KD, Clarke R, Nephew KP.

Cancers (Basel). 2019 Jan 4;11(1). pii: E43. doi: 10.3390/cancers11010043.

17.

Cancer statistics, 2019.

Siegel RL, Miller KD, Jemal A.

CA Cancer J Clin. 2019 Jan;69(1):7-34. doi: 10.3322/caac.21551. Epub 2019 Jan 8.

18.

Equitably improving outcomes for cancer survivors and supporting caregivers: A blueprint for care delivery, research, education, and policy.

Alfano CM, Leach CR, Smith TG, Miller KD, Alcaraz KI, Cannady RS, Wender RC, Brawley OW.

CA Cancer J Clin. 2019 Jan;69(1):35-49. doi: 10.3322/caac.21548. Epub 2018 Oct 30.

19.

Safety and pharmacokinetics of MM-302, a HER2-targeted antibody-liposomal doxorubicin conjugate, in patients with advanced HER2-positive breast cancer: a phase 1 dose-escalation study.

Munster P, Krop IE, LoRusso P, Ma C, Siegel BA, Shields AF, Molnár I, Wickham TJ, Reynolds J, Campbell K, Hendriks BS, Adiwijaya BS, Geretti E, Moyo V, Miller KD.

Br J Cancer. 2018 Oct;119(9):1086-1093. doi: 10.1038/s41416-018-0235-2. Epub 2018 Oct 26.

PMID:
30361524
20.

The submental arrowhead variation of the mylohyoid and anterior belly of the digastric muscles.

Zdilla MJ, Mangus KR, Swearingen JV, Miller KD, Lambert HW.

Surg Radiol Anat. 2018 Dec;40(12):1429-1436. doi: 10.1007/s00276-018-2110-5. Epub 2018 Oct 10.

PMID:
30306209
21.

Cancer Statistics for Hispanics/Latinos, 2018.

Miller KD, Goding Sauer A, Ortiz AP, Fedewa SA, Pinheiro PS, Tortolero-Luna G, Martinez-Tyson D, Jemal A, Siegel RL.

CA Cancer J Clin. 2018 Nov;68(6):425-445. doi: 10.3322/caac.21494. Epub 2018 Oct 4.

22.

How biological attention mechanisms improve task performance in a large-scale visual system model.

Lindsay GW, Miller KD.

Elife. 2018 Oct 1;7. pii: e38105. doi: 10.7554/eLife.38105.

23.

Home Is Where the HeartWare Is: Preparing Pediatric Patients and Caregivers for Discharge to Home and Integration Into the Community.

DiFusco LA, Patton AM, White RM, Bober CM, Miller KD.

ASAIO J. 2018 Nov/Dec;64(6):e166-e171. doi: 10.1097/MAT.0000000000000846.

PMID:
30199384
24.

Fitting psychotherapy to patient coping style: A meta-analysis.

Beutler LE, Kimpara S, Edwards CJ, Miller KD.

J Clin Psychol. 2018 Nov;74(11):1980-1995. doi: 10.1002/jclp.22684. Epub 2018 Sep 10.

PMID:
30198566
25.

The implications of insurance status on presentation, surgical management, and mortality among nonmetastatic breast cancer patients in Indiana.

Obeng-Gyasi S, Timsina L, Miller KD, Ludwig KK, Fisher CS, Haggstrom DA.

Surgery. 2018 Dec;164(6):1366-1371. doi: 10.1016/j.surg.2018.07.012. Epub 2018 Aug 28.

PMID:
30170816
26.

Impact of primary breast cancer therapy on energetic capacity and body composition.

Ballinger TJ, Reddy A, Althouse SK, Nelson EM, Miller KD, Sledge JS.

Breast Cancer Res Treat. 2018 Nov;172(2):445-452. doi: 10.1007/s10549-018-4924-6. Epub 2018 Aug 22.

27.

A phase II clinical trial of the Aurora and angiogenic kinase inhibitor ENMD-2076 for previously treated, advanced, or metastatic triple-negative breast cancer.

Diamond JR, Eckhardt SG, Pitts TM, van Bokhoven A, Aisner D, Gustafson DL, Capasso A, Sams S, Kabos P, Zolman K, Colvin T, Elias AD, Storniolo AM, Schneider BP, Gao D, Tentler JJ, Borges VF, Miller KD.

Breast Cancer Res. 2018 Aug 2;20(1):82. doi: 10.1186/s13058-018-1014-y.

28.

Association of Circulating Tumor Cells With Late Recurrence of Estrogen Receptor-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.

Sparano J, O'Neill A, Alpaugh K, Wolff AC, Northfelt DW, Dang CT, Sledge GW, Miller KD.

JAMA Oncol. 2018 Dec 1;4(12):1700-1706. doi: 10.1001/jamaoncol.2018.2574.

29.

Double-Blind Phase III Trial of Adjuvant Chemotherapy With and Without Bevacizumab in Patients With Lymph Node-Positive and High-Risk Lymph Node-Negative Breast Cancer (E5103).

Miller KD, O'Neill A, Gradishar W, Hobday TJ, Goldstein LJ, Mayer IA, Bloom S, Brufsky AM, Tevaarwerk AJ, Sparano JA, Le-Lindqwister NA, Hendricks CB, Northfelt DW, Dang CT, Sledge GW Jr.

J Clin Oncol. 2018 Sep 1;36(25):2621-2629. doi: 10.1200/JCO.2018.79.2028. Epub 2018 Jul 24.

30.

Ovarian cancer statistics, 2018.

Torre LA, Trabert B, DeSantis CE, Miller KD, Samimi G, Runowicz CD, Gaudet MM, Jemal A, Siegel RL.

CA Cancer J Clin. 2018 Jul;68(4):284-296. doi: 10.3322/caac.21456. Epub 2018 May 29.

31.

Higher Lung Cancer Incidence in Young Women Than Young Men in the United States.

Jemal A, Miller KD, Ma J, Siegel RL, Fedewa SA, Islami F, Devesa SS, Thun MJ.

N Engl J Med. 2018 May 24;378(21):1999-2009. doi: 10.1056/NEJMoa1715907.

32.

The Dynamical Regime of Sensory Cortex: Stable Dynamics around a Single Stimulus-Tuned Attractor Account for Patterns of Noise Variability.

Hennequin G, Ahmadian Y, Rubin DB, Lengyel M, Miller KD.

Neuron. 2018 May 16;98(4):846-860.e5. doi: 10.1016/j.neuron.2018.04.017.

33.

Metastatic breast cancer patients' expectations and priorities for symptom improvement.

Tometich DB, Mosher CE, Hirsh AT, Rand KL, Johns SA, Matthias MS, Outcalt SD, Schneider BP, Mina L, Storniolo AMV, Newton EV, Miller KD.

Support Care Cancer. 2018 Nov;26(11):3781-3788. doi: 10.1007/s00520-018-4244-8. Epub 2018 May 7.

PMID:
29736866
34.

Randomized Phase II Trial of Fulvestrant Plus Everolimus or Placebo in Postmenopausal Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Resistant to Aromatase Inhibitor Therapy: Results of PrE0102.

Kornblum N, Zhao F, Manola J, Klein P, Ramaswamy B, Brufsky A, Stella PJ, Burnette B, Telli M, Makower DF, Cheema P, Truica CI, Wolff AC, Soori GS, Haley B, Wassenaar TR, Goldstein LJ, Miller KD, Sparano JA.

J Clin Oncol. 2018 Jun 1;36(16):1556-1563. doi: 10.1200/JCO.2017.76.9331. Epub 2018 Apr 17.

PMID:
29664714
35.

Spotlight on dabrafenib/trametinib in the treatment of non-small-cell lung cancer: place in therapy.

Weart TC, Miller KD, Simone CB 2nd.

Cancer Manag Res. 2018 Apr 3;10:647-652. doi: 10.2147/CMAR.S142269. eCollection 2018. Review.

36.

A Preliminary Study of Left Ventricular Rotational Mechanics in Children with Noncompaction Cardiomyopathy: Do They Influence Ventricular Function?

Nawaytou HM, Montero AE, Yubbu P, Calderón-Anyosa RJC, Sato T, O'Connor MJ, Miller KD, Ursell PC, Hoffman JIE, Banerjee A.

J Am Soc Echocardiogr. 2018 Aug;31(8):951-961. doi: 10.1016/j.echo.2018.02.015. Epub 2018 Apr 13.

37.

An Effective Epigenetic-PARP Inhibitor Combination Therapy for Breast and Ovarian Cancers Independent of BRCA Mutations.

Pulliam N, Fang F, Ozes AR, Tang J, Adewuyi A, Keer H, Lyons J, Baylin SB, Matei D, Nakshatri H, Rassool FV, Miller KD, Nephew KP.

Clin Cancer Res. 2018 Jul 1;24(13):3163-3175. doi: 10.1158/1078-0432.CCR-18-0204. Epub 2018 Apr 3.

38.

E2112: randomized phase iii trial of endocrine therapy plus entinostat/placebo in patients with hormone receptor-positive advanced breast cancer.

Yeruva SLH, Zhao F, Miller KD, Tevaarwerk AJ, Wagner LI, Gray RJ, Sparano JA, Connolly RM.

NPJ Breast Cancer. 2018 Jan 11;4:1. doi: 10.1038/s41523-017-0053-3. eCollection 2018. Review.

39.

Impact of Genetic Ancestry on Outcomes in ECOG-ACRIN-E5103.

Schneider BP, Shen F, Jiang G, O'Neill A, Radovich M, Li L, Gardner L, Lai D, Foroud T, Sparano JA, Sledge GW Jr, Miller KD.

JCO Precis Oncol. 2017;2017. doi: 10.1200/PO.17.00059. Epub 2017 Aug 21.

40.

The Use of Ultrasonography to Identify the Intersection of the Dorsomedial Cutaneous Nerve of the Hallux and the Extensor Hallucis Longus Tendon: A Cadaveric Study.

Zdilla MJ, Miller KD, Swearingen JV, Lambert HW.

J Foot Ankle Surg. 2018 Mar - Apr;57(2):296-300. doi: 10.1053/j.jfas.2017.10.007. Epub 2018 Jan 11.

PMID:
29331290
41.

Acceptance and commitment therapy for symptom interference in metastatic breast cancer patients: a pilot randomized trial.

Mosher CE, Secinti E, Li R, Hirsh AT, Bricker J, Miller KD, Schneider B, Storniolo AM, Mina L, Newton EV, Champion VL, Johns SA.

Support Care Cancer. 2018 Jun;26(6):1993-2004. doi: 10.1007/s00520-018-4045-0. Epub 2018 Jan 12.

42.

Cancer statistics, 2018.

Siegel RL, Miller KD, Jemal A.

CA Cancer J Clin. 2018 Jan;68(1):7-30. doi: 10.3322/caac.21442. Epub 2018 Jan 4.

43.

A Unifying Motif for Spatial and Directional Surround Suppression.

Liu LD, Miller KD, Pack CC.

J Neurosci. 2018 Jan 24;38(4):989-999. doi: 10.1523/JNEUROSCI.2386-17.2017. Epub 2017 Dec 11.

44.

Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States.

Islami F, Goding Sauer A, Miller KD, Siegel RL, Fedewa SA, Jacobs EJ, McCullough ML, Patel AV, Ma J, Soerjomataram I, Flanders WD, Brawley OW, Gapstur SM, Jemal A.

CA Cancer J Clin. 2018 Jan;68(1):31-54. doi: 10.3322/caac.21440. Epub 2017 Nov 21.

45.

Response.

Siegel RL, Fedewa SA, Anderson WF, Miller KD, Ma J, Rosenberg PS, Jemal A.

J Natl Cancer Inst. 2017 Aug 1;109(8). doi: 10.1093/jnci/djx100. No abstract available.

46.

A system for detecting high impact-low frequency mutations in primary tumors and metastases.

Anjanappa M, Hao Y, Simpson ER, Bhat-Nakshatri P, Nelson JB, Tersey SA, Mirmira RG, Cohen-Gadol AA, Saadatzadeh MR, Li L, Fang F, Nephew KP, Miller KD, Liu Y, Nakshatri H.

Oncogene. 2018 Jan 11;37(2):185-196. doi: 10.1038/onc.2017.322. Epub 2017 Sep 11.

47.

Systemic Atrioventricular Valve Excision and Ventricular Assist Devices in Pediatric Patients.

Nandi D, Miller KD, Bober CM, Rosenthal TM, Montenegro LM, Rossano JW, Gaynor JW, Mascio CE.

Ann Thorac Surg. 2018 Jan;105(1):170-174. doi: 10.1016/j.athoracsur.2017.05.038. Epub 2017 Aug 16.

48.

Colorectal Cancer Mortality Rates in Adults Aged 20 to 54 Years in the United States, 1970-2014.

Siegel RL, Miller KD, Jemal A.

JAMA. 2017 Aug 8;318(6):572-574. doi: 10.1001/jama.2017.7630. No abstract available.

49.

Next-generation sequencing of circulating tumor DNA to predict recurrence in triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy.

Chen YH, Hancock BA, Solzak JP, Brinza D, Scafe C, Miller KD, Radovich M.

NPJ Breast Cancer. 2017 Jul 3;3:24. doi: 10.1038/s41523-017-0028-4. eCollection 2017.

50.

Does biomarker information impact breast cancer patients' preferences and physician recommendation for adjuvant chemotherapy?

Partridge AH, Sepucha K, O'Neill A, Miller KD, Baker E, Dang CT, Northfelt DW, Sledge GW, Schneider BP.

Breast Cancer Res Treat. 2017 Oct;165(3):545-553. doi: 10.1007/s10549-017-4338-x. Epub 2017 Jun 23.

Supplemental Content

Loading ...
Support Center